drugset / Trial / NCT05922878
Study of ALTO-300 in MDD
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine efficacy differences between ALTO-300 and placebo, used adjunctively to an antidepressant, related to patient characteristics.
Timeline
- Start
- 2023-06-08
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALTO-300 | Unknown | — | — |